Picture of Fulgent Genetics logo

FLGT — Fulgent Genetics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapSuper Stock

Fulgent Genetics Inc expected to post earnings of $2.61 a share - Earnings Preview

* Fulgent Genetics Inc  FLGT.OQ   FLGT.O  is expected
to show a
fall in quarterly revenue when it reports  results on February
23. 
    * The Temple City California-based  company is expected to
report 
a 35.2% decrease in revenue to $191.1 million from $294.98
million a year ago, according to the mean estimate from 3
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Fulgent Genetics
Inc is
for earnings of $2.61 per share. For the same quarter last year,
the company reported earnings of $6.20 per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Fulgent
Genetics
Inc is $102.5​, about 37.7% above​ its last closing price
of $63.85. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2021  3.25        3.25       3.95      Beat    21.7
 Jun. 30 2021  2.78        2.76       2.47      Missed  -10.4
 Mar. 31 2021  5.82        5.86       6.59      Beat    12.5​
 Dec. 31 2020  4.30        4.05       6.20      Beat    52.9
 ​​Sep.        0.55        0.55       2.08      Beat    277.3
 30 2020                                                
 Jun. 30 2020  -0.01       -0.02      0.17      Beat    1,044.
                                                        4​
 Mar. 31 2020  0.02        0.02       -0.03     Missed  -242.9
 Dec. 31 2019              0.04       0.04      Met     1.3
 This summary was machine generated February 22 at 03:04 GMT. 
All figures in US dollars  unless otherwise stated

Recent news on Fulgent Genetics

See all news